Literature DB >> 28581410

Lung and Heart Dose Variability During Radiation Therapy of Non-Small Cell Lung Cancer.

Nuzhat Jan1, Christopher Guy1, Leonid B Reshko1, Geoffrey D Hugo1, Elisabeth Weiss2.   

Abstract

PURPOSE: To investigate the hypothesis that positional and anatomic variations during radiation therapy induce changes in lung and heart volumes and associated radiation doses. METHODS AND MATERIALS: In this longitudinal investigation, variations in lung and heart volumes and standard dose parameters of mean lung dose, lung V20Gy, mean heart dose, and heart V40Gy were analyzed on weekly 4-dimensional CT scans of 15 lung cancer patients during conventionally fractionated radiochemotherapy. Tumor, individual lung lobes, and heart were delineated on the mid-ventilation phase of weekly 4-dimensional CT scans. Lung lobes and heart were also contoured on individual breathing phases of pre-, mid-, and end-of-treatment scans. Planning dose was transferred to consecutive scans via rigid registration. Volume and dose variations were assessed relative to the initial planning scan.
RESULTS: Interfraction lung volume variability relative to week 0 was twice as large as tidal volume variability (8.0% ± 5.3% vs 4.0% ± 3.3%, P=.003). Interfraction lung volume variation ranged between 0.8% and 17.1% for individual patient means. Lower lung lobes had larger volume variability compared with upper lobes (13.5% ± 8.1% vs 7.0% ± 5.0%, P<.00001). Average mean lung dose variation was 0.5 Gy (range, 0.2-1.0 Gy for individual patient means) and average lung V20Gy variation 0.9% (range, 0.2%-1.6%). Average heart volume variation was 7.2% (range, 3.4%-12.6%). Average mean heart dose variation was 1.2 Gy (range, 0.1-3.0 Gy) and average heart V40Gy variation 1.4% (range, 0%-4.2%).
CONCLUSIONS: Anatomic and positional variations during radiation therapy induce changes in radiation doses to lung and heart. Repeated lung and heart dose assessment will provide a better estimate of the actual delivered dose and will improve prediction models for normal tissue toxicity, if assessed in larger cohorts.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28581410      PMCID: PMC5527748          DOI: 10.1016/j.ijrobp.2017.02.227

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  30 in total

Review 1.  Radiation dose-volume effects in the lung.

Authors:  Lawrence B Marks; Soren M Bentzen; Joseph O Deasy; Feng-Ming Spring Kong; Jeffrey D Bradley; Ivan S Vogelius; Issam El Naqa; Jessica L Hubbs; Joos V Lebesque; Robert D Timmerman; Mary K Martel; Andrew Jackson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

2.  Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy.

Authors:  Ellen D Yorke; Andrew Jackson; Kenneth E Rosenzweig; Scott A Merrick; Dorota Gabrys; Ennapadam S Venkatraman; Chandra M Burman; Steven A Leibel; C Clifton Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-10-01       Impact factor: 7.038

3.  Reduction of heart volume during neoadjuvant chemoradiation in patients with resectable esophageal cancer.

Authors:  Nadia Haj Mohammad; Martijn Kamphuis; Maarten C C M Hulshof; Lotte J Lutkenhaus; Suzanne S Gisbertz; Jacques J G H M Bergman; H A C M Rianne de Bruin-Bon; Elisabeth D Geijsen; Arjan Bel; S Mathijs Boekholdt; Hanneke W M van Laarhoven
Journal:  Radiother Oncol       Date:  2015-01-24       Impact factor: 6.280

4.  Functional image-guided radiotherapy planning in respiratory-gated intensity-modulated radiotherapy for lung cancer patients with chronic obstructive pulmonary disease.

Authors:  Tomoki Kimura; Ikuno Nishibuchi; Yuji Murakami; Masahiro Kenjo; Yuko Kaneyasu; Yasushi Nagata
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-13       Impact factor: 7.038

Review 5.  Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis.

Authors:  David A Palma; Suresh Senan; Kayoko Tsujino; Robert B Barriger; Ramesh Rengan; Marta Moreno; Jeffrey D Bradley; Tae Hyun Kim; Sara Ramella; Lawrence B Marks; Luigi De Petris; Larry Stitt; George Rodrigues
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-09       Impact factor: 7.038

6.  Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.

Authors:  Matthias Guckenberger; Juergen Wilbert; Anne Richter; Kurt Baier; Michael Flentje
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-12       Impact factor: 7.038

7.  A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.

Authors:  Line Claude; David Pérol; Chantal Ginestet; Lionel Falchero; Dominique Arpin; Michel Vincent; Isabelle Martel; Stéphane Hominal; Jean-François Cordier; Christian Carrie
Journal:  Radiother Oncol       Date:  2004-05       Impact factor: 6.280

8.  Dosimetric evaluation of anatomical changes during treatment to identify criteria for adaptive radiotherapy in oesophageal cancer patients.

Authors:  Tine Bisballe Nyeng; Marianne Nordsmark; Lone Hoffmann
Journal:  Acta Oncol       Date:  2015-07-29       Impact factor: 4.089

9.  Impact of heart and lung dose on early survival in patients with non-small cell lung cancer treated with chemoradiation.

Authors:  Susan L Tucker; Anwen Liu; Daniel Gomez; Ling Long Tang; Pamela Allen; Jinzhong Yang; Zhongxing Liao; David Grosshans
Journal:  Radiother Oncol       Date:  2016-05-14       Impact factor: 6.280

10.  Changes in functional lung regions during the course of radiation therapy and their potential impact on lung dosimetry for non-small cell lung cancer.

Authors:  Xue Meng; Kirk Frey; Martha Matuszak; Stanton Paul; Randall Ten Haken; Jinming Yu; Feng-Ming Spring Kong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-01       Impact factor: 7.038

View more
  6 in total

1.  Radiation Therapy Is Associated With an Increased Incidence of Cardiac Events in Patients with Small Cell Lung Cancer.

Authors:  Matthew J Ferris; Renjian Jiang; Madhusmita Behera; Suresh S Ramalingam; Walter J Curran; Kristin A Higgins
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-06-06       Impact factor: 7.038

2.  Treatment outcomes of patients with stage III non-small cell lung cancer and interstitial lung diseases receiving intensity-modulated radiation therapy: A single-center experience of 85 cases.

Authors:  Linfang Wu; Shijun Zhao; Hui Huang; Wenqing Wang; Tao Zhang; Zongmei Zhou; Qinfu Feng; Jun Liang; Zefen Xiao; Zhouguang Hui; Jima Lv; Nan Bi; Luhua Wang
Journal:  Thorac Cancer       Date:  2022-04-22       Impact factor: 3.223

3.  Cardiac radiation dose distribution, cardiac events and mortality in early-stage lung cancer treated with stereotactic body radiation therapy (SBRT).

Authors:  Leonid B Reshko; Noah S Kalman; Geoffrey D Hugo; Elisabeth Weiss
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

4.  Intrafractional Displacement of Cardiac Substructures Among Patients With Mediastinal Lymphoma or Lung Cancer.

Authors:  Lidia Guzhva; Stella Flampouri; Nancy P Mendenhall; Christopher G Morris; Bradford S Hoppe
Journal:  Adv Radiat Oncol       Date:  2019-03-29

5.  Primary site as a novel prognostic factor for cardiovascular mortality post-radiotherapy in limited-stage small cell lung cancer: A large population-based study.

Authors:  Yuwei Zhao; Fen Qin; Qingqi Ji; Wuyan Xia; Ben He
Journal:  Front Cardiovasc Med       Date:  2022-08-12

6.  A clinical 3D/4D CBCT-based treatment dose monitoring system.

Authors:  An Qin; David Gersten; Jian Liang; Qiang Liu; Inga Grill; Thomas Guerrero; Craig Stevens; Di Yan
Journal:  J Appl Clin Med Phys       Date:  2018-10-10       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.